EMORY INTEGRATED PROTEOMICS SHARED RESOURCE PROJECT SUMMARY / ABSTRACT The mission of the Emory Integrated Proteomics Shared Resources (Proteomics SR) is to provide protein analytical services using cutting-edge mass spectrometry (MS) in support of Winship Cancer Institute. The main technology platform of Proteomics SR is liquid chromatography coupled with tandem mass spectrometry (LC- MS/MS) for highly sensitive identification and quantification of proteins and their post-translational modifications (PTMs). Proteomics SR is a critical technological resource for Winship investigators and has supported a broad range of cancer projects related to cancer cell biology, genetics, epigenetics, and novel therapeutics. The primary aims of the of Proteomics SR are to provide: (1) access to state-of-the-art mass spectrometry for both discovery and targeted proteomic applications, (2) provide consultation, expert training, and support for proteomics-related research projects, and (3) provide infrastructure and resources that advance collaborative multidisciplinary research and innovation among Winship investigators. Collectively, these aims will lead to an increase in the quality of proteomics data available to Winship investigators through experimental design optimization and proper interpretation. The mass spectrometry technologies provided are vital to Winship researchers and key findings from these proteomic studies are fundamental to Winship's efforts to improve the prevention, detection, and treatment of human cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138292-11
Application #
9685140
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
11
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Halicek, Martin; Little, James V; Wang, Xu et al. (2018) Deformable Registration of Histological Cancer Margins to Gross Hyperspectral Images using Demons. Proc SPIE Int Soc Opt Eng 10581:
Cassidy, Richard J; Switchenko, Jeffrey M; El-Deiry, Mark W et al. (2018) Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. Laryngoscope :
Mukherjee, Subhas; Tucker-Burden, Carol; Kaissi, Emily et al. (2018) CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells. Cell Rep 23:1651-1664
Thompson, Jeffrey A; Christensen, Brock C; Marsit, Carmen J (2018) Methylation-to-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, and Pathologic Complete Response in Multiple Cohorts. Sci Rep 8:5190
Sadigh, Gelareh; Holder, Chad A; Switchenko, Jeffrey M et al. (2018) Is there added value in obtaining cervical spine MRI in the assessment of nontraumatic angiographically negative subarachnoid hemorrhage? A retrospective study and meta-analysis of the literature. J Neurosurg 129:670-676
Allen, Samuel C; Lohani, Minisha; Hendershot, Kristopher A et al. (2018) Patient perspectives on compensation for biospecimen donation. AJOB Empir Bioeth 9:77-81
Cassidy, Richard J; Switchenko, Jeffrey M; Yushak, Melinda L et al. (2018) The importance of surgery in scalp angiosarcomas. Surg Oncol 27:A3-A8
Owonikoko, Taofeek K; Busari, Adeniyi K; Kim, Sungjin et al. (2018) Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials. Oncology 95:138-146
Koff, Jean L; Li, Jing-Xia; Zhang, Xinyan et al. (2018) Impact of the posttransplant lymphoproliferative disorder subtype on survival. Cancer 124:2327-2336
Dennison, Cori; King, Adrian R; Rutledge, Hannah et al. (2018) HPV Vaccine-Related Research, Promotion and Coordination in the State of Georgia: A Systematic Review. J Community Health :

Showing the most recent 10 out of 331 publications